Quirine A. ten Bosch

Biased efficacy estimates in phase-III dengue vaccine trials due to heterogeneous exposure and differential detectability of primary infections across trial arms

Guido España, Cosmina Hogea, Adrienne Guignard et al. · PLoS ONE · 2019 · 734 citations · Full text

Vaccination, Dengue Vaccine Candidates, Infectious Disease Modelling +14

Contributions from the silent majority dominate dengue virus transmission

Quirine A. ten Bosch, Hannah Clapham, Louis Lambrechts et al. · PLoS Pathogens · 2018 · 165 citations · Full text

Implementation and applications of EMOD, an individual-based multi-disease modeling platform

Anna Bershteyn, Jaline Gerardin, Daniel Bridenbecker et al. · Pathogens and Disease · 2018 · 110 citations · Full text

Engineering, Malaria, System Medicine +22

Lovastatin Induces Neuroprotection Through Tumor Necrosis Factor Receptor 2 Signaling Pathways

Amalia M. Dolga, Ingrid M. Nijholt, Anghelus Ostroveanu et al. · Journal of Alzheimer s Disease · 2008 · 60 citations · Full text

Over 100 Years of Rift Valley Fever: A Patchwork of Data on Pathogen Spread and Spillover

Gebbiena M. Bron, Kathryn Strimbu, Hélène Cecilia et al. · Pathogens · 2021 · 49 citations · Full text

Virus Epidemiology, Cryptic Spread, Epidemiological Dynamic +17